Latest News:
FDA Approves Oxbryta™ (Voxelotor), the First Medicine Specifically Targeting the Root Cause of Sickle Cell Disease
TIF will coordinate efforts for patients’ information on Reblozyl in 62 countries
New and Updated Data on Key Thalassaemia & SCD Pipeline Therapies at the American Society of Hematology (ASH) 2019 Annual Meeting – 7-10 December 2019
Deferasirox Mylan: A new generic drug for the treatment of iron overload in β-thalassaemia major obtained approval by the EMA
US government & Gates Foundation pledge $200 million to bring gene therapies to patients with Sickle Cell Disease & HIV
ar
de
el
en
fr
it
TIF
About
Education
Country work
Positions & Policies
Projects
Publications
News & Events
Contact
Home
»
Publications
»
TIF Magazine
TIF Magazine
Issue 62 – March 2013
August 5, 2017
Read More »
Issue 63 – November 2013
August 5, 2017
Read More »
Issue 64 – May 2014
August 5, 2017
Read More »
Issue 65 – October 2014
August 5, 2017
Read More »
Issue 66 – May 2015
August 5, 2017
Read More »
Issue 67 – December 2015
August 5, 2017
Read More »
Issue 68 – August 2016
August 5, 2017
Read More »
Issue 61 – September 2012
August 5, 2017
Read More »
Issue 58 – November 2010
August 5, 2017
Read More »
Issue 60 – December 2011
August 5, 2017
Read More »
Page 1 of 2
1
2
»
Cookies
This site uses cookies.
Find out more
Okay, thanks